NIH-funded research Fellowship grant

Investigating how iron affects eye damage during bacterial infections

Official title: The role of iron in retinal degeneration during bacterial infection

Funded at University of Pennsylvania · NIH-10884871 · Data updated 2026-11-12

This study is looking at how iron affects serious eye infections that can cause vision loss, and it aims to find a way to use a special treatment to help stop bacteria from growing and protect your eyesight.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endFebruary 19, 2027
Funding year2024
Award (this year)$48,974
NIH project number5F31EY035141-02
Project IDNIH-10884871 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of developing endophthalmitis, particularly those undergoing intraocular surgery.

Less likely to help

Patients with eye infections not caused by bacterial agents or those with pre-existing irreversible vision loss may not benefit from this research.

What this research studies

This research focuses on understanding the role of iron in the development of severe eye infections known as endophthalmitis, which can lead to permanent vision loss. The study aims to explore how bacteria compete for iron during infection and how this competition can lead to inflammation and damage to the retina. By using animal models, the researchers will test the effectiveness of an iron chelator, a substance that binds to iron, to inhibit bacterial growth and protect retinal structure. The goal is to find a treatment that can reduce both bacterial proliferation and inflammation in the eye.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent vision loss in patients suffering from severe eye infections.

How similar studies have gone: Previous research has shown that iron chelation can effectively inhibit bacterial growth and reduce inflammation in various infections, suggesting a promising approach in this context.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Foshe, Sierra — University of Pennsylvania
  • Study coordinator: Foshe, Sierra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.